Featured News

The PROACTIVE Celiac Study is a phase 2 clinical trial testing the safety and effects of the investigational medication PRV-015.

If you have unexplained symptoms or have a family member with celiac disease, complete the Symptoms Assessment Tool to see if you have an increased risk for celiac disease – and receive a free product from CDF Proud Sponsor Schär. 

The need for action is clear. The failure to understand and treat celiac disease appropriately manifests in low rates of diagnosis, lack of research funding and alternative treatments, and limited understanding of the economic and social costs of this disease. 

Meet our runners for the 2022 TCS NYC Marathon!

Consider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.

Joining or creating a team for the Virtual Turkey Trot can boost your fundraising goals and accelerate the diagnosis and treatment of celiac disease.  

Listen in as Marilyn G. Geller, Chief Executive Officer of the Celiac Disease Foundation, talks with Mike and Cam at the Celiac Project Podcast about some of the exciting work we’re doing.

Join Columbia University for an educational event on August 19th on the management of celiac disease after diagnosis. This is the second in a series of 10 bimonthly programs and is open to healthcare professionals and patients.

iCureCeliac® is the Foundation’s patient-powered tool that is the single best resource for celiac disease researchers around the world helping to accelerate the search for treatments and a cure.

We are pleased to introduce a new 7-Day Mediterranean Diet Meal Plan, developed by Janelle Smith, Registered Dietitian at UCLA.